News

Anyone who has ever put a baby to sleep by gently cradling it or has ever taken a nap in a hammock knows that rocking promotes sleep. But why? A new study shows that slow and repeated movement throughout the night modulates brain wave activity. Consequently, not only does balancing induce deeper sleep, but it also helps to strengthen memory, which is consolidated during certain sleep phases.

A team that includes the scientist who first harnessed the revolutionary CRISPR-Cas9 and other systems for genome editing of eukaryotic organisms, including animals and plants, has engineered another CRISPR system, called Cas12b.

In a recent paper published in Communications Biology, a research team led by Osaka University has uncovered the role of heterochromatin in maintaining chromosomal integrity.

Should regulations for environmental protection be valid beyond our solar system? Currently, extra-terrestrial forms of life are only deemed worth protecting if they can be scientifically investigated.

A newly developed graphene-based implant can record electrical activity in the brain at extremely low frequencies and over large areas, unlocking the wealth of information found below 0.1 Hz. A new study, just published in Nature Materials, describes how this ground-breaking technology will enhance our understanding of the brain and pave the way for the next generation of brain-computer interfaces.

In the largest study of its kind to date, researchers have looked at why some people manage to stay thin while others gain weight easily. They have found that the genetic dice are loaded in favour of thin people and against those at the obese end of the spectrum.

Nearly two decades after a class of once-promising cancer drugs called MMP inhibitors mysteriously failed in clinical trials, scientists think they may have an explanation for what went wrong.

The investigational Ebola treatment mAb114 is safe, well-tolerated, and easy to administer, according to findings from an early-stage clinical trial published in The Lancet.

A new approach using multiple microRNA ‘hitchhikers’ to weaken cancer cells in advance of standard therapy shows promise in preclinical models.

During development in the womb, immune cells called macrophages go to the kidneys, and they remain there for life. Understanding the possible healing role for these macrophages after kidney damage may be crucial to helping treat patients who suffer acute kidney injury.